Literature DB >> 19601853

The complement cascade: new avenues in stroke therapy.

Ricardo J Komotar1, Robert M Starke, Eric J Arias, Matthew C Garrett, Marc L Otten, Maxwell B Merkow, Benjamin Hassid, J Mocco, Michael E Sughrue, Grace H Kim, William J Mack, Andrew F Ducruet, E Sander Connolly.   

Abstract

Recent evidence has shown that after the initial occlusion, a large portion of stroke patients achieve some degree of reperfusion either through collateral circulation or clot dissolution. However, it appears that this reperfusion may lead to increased inflammation-induced damage. Even though the exact mechanism of this secondary injury is unclear, several experimental studies have indicated an intimate connection between complement and this secondary form of damage. We review the available literature and attempt to identify promising clinical therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601853     DOI: 10.2174/157016109788340677

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  2 in total

1.  Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.

Authors:  Paul R Gigante; Ivan S Kotchetkov; Christopher P Kellner; Raqeeb Haque; Andrew F Ducruet; Brian Y Hwang; Robert A Solomon; Eric J Heyer; E Sander Connolly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-14       Impact factor: 10.154

2.  Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice.

Authors:  Denise Harhausen; Uldus Khojasteh; Philip F Stahel; B Paul Morgan; Wilfried Nietfeld; Ulrich Dirnagl; George Trendelenburg
Journal:  J Neuroinflammation       Date:  2010-03-04       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.